Screener
Nuvation Bio NUVB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| For the Six Months Ended June 30, | 2026 | 2025 |
|---|---|---|
| Payments on revenue interest financing agreement | (1,882) | — |
| Proceeds from issuance of Common Stock under ESPP | 1,247 | 533 |
| Proceeds from exercises of options | 4,409 | 1,844 |
| Net cash provided by financing activities | 170,573 | 193,971 |
| Effect of foreign exchange rate changes on cash and cash equivalents | (510) | 23 |
| Net increase in cash and cash equivalents | 94,518 | 212,247 |
| Cash and cash equivalents, beginning of the period | 164,086 | 35,723 |
| Cash and cash equivalents, end of the period | $258,604 | $247,970 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's financing cash flow?
- Nuvation Bio (NUVB) reported financing cash flow of $170.53M in Q2 2026.
- How has Nuvation Bio's financing cash flow changed year-over-year?
- Nuvation Bio's financing cash flow decreased by 11.8% year-over-year, from $193.42M to $170.53M.
- What is the long-term trend for Nuvation Bio's financing cash flow?
- Over 2 years (2021 to 2025), Nuvation Bio's financing cash flow has grown at a -43.1% compound annual growth rate (CAGR), from $625.56M to $202.54M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Nuvation Bio's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude